Furthermore, 69% of these EPIs showed enriched epigenomic activity and/or gene expression in NF-κB + MM tumours, especially for those bound by p52 at their enhancers (80%) (Fig. 5c). This evidence concerns the gene NFKB1 and Miyoshi myopathy.